UPDATE: UBS Starts Akebia Therapeutics (AKBA) at Buy

April 14, 2014 8:14 AM EDT Send to a Friend
(Updated - April 14, 2014 1:37 PM EDT)

UBS initiated coverage on Akebia Therapeutics (NASDAQ: AKBA) with a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login